- Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence
-
Kiaie N, Mousavi Ghanavati SP, Miremadi SS, Hadipour A, Aghdam RM
- KMID: 2519368
- Int J Stem Cells.
- 2021 Aug;14(3):252-261.
- doi: 10.15283/ijsc20182
Since the emergence of the novel coronavirus, named COVID-19, researchers are looking for a treatment to stop the devastating pandemic. During these efforts, mesenchymal stem cells (MSCs), the potential next... -
- CITED
-
- Close
- SHARE
-
- Close
